- Home
- TCRX vs USAU Comparison
TCRX vs USAU Comparison
Compare TCRX & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- USAU
- Stock Information
- Founded
- TCRX 2018
- USAU 2014
- Country
- TCRX United States
- USAU United States
- Employees
- TCRX N/A
- USAU N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- USAU Precious Metals
- Sector
- TCRX Health Care
- USAU Basic Materials
- Exchange
- TCRX Nasdaq
- USAU Nasdaq
- Market Cap
- TCRX 140.7M
- USAU 126.8M
- IPO Year
- TCRX 2021
- USAU N/A
- Fundamental
- Price
- TCRX $1.89
- USAU $15.06
- Analyst Decision
- TCRX Strong Buy
- USAU Strong Buy
- Analyst Count
- TCRX 5
- USAU 3
- Target Price
- TCRX $9.40
- USAU $19.00
- AVG Volume (30 Days)
- TCRX 656.4K
- USAU 421.8K
- Earning Date
- TCRX 11-07-2025
- USAU 12-15-2025
- Dividend Yield
- TCRX N/A
- USAU N/A
- EPS Growth
- TCRX N/A
- USAU N/A
- EPS
- TCRX N/A
- USAU N/A
- Revenue
- TCRX $6,961,000.00
- USAU N/A
- Revenue This Year
- TCRX $255.18
- USAU N/A
- Revenue Next Year
- TCRX N/A
- USAU N/A
- P/E Ratio
- TCRX N/A
- USAU N/A
- Revenue Growth
- TCRX N/A
- USAU N/A
- 52 Week Low
- TCRX $1.02
- USAU $5.59
- 52 Week High
- TCRX $6.23
- USAU $19.20
- Technical
- Relative Strength Index (RSI)
- TCRX 39.56
- USAU 40.32
- Support Level
- TCRX $1.74
- USAU $15.12
- Resistance Level
- TCRX $2.43
- USAU $16.00
- Average True Range (ATR)
- TCRX 0.18
- USAU 0.96
- MACD
- TCRX -0.07
- USAU -0.48
- Stochastic Oscillator
- TCRX 14.46
- USAU 3.57
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.